Using the conditioned fear stress (CFS) animal model to understand the neurobiological mechanisms and pharmacological treatment of anxiety

Shanghai Archives of Psychiatry

Volumn 24, Issue 5, 2012, Pages 241-249

  Li, Xiaobai ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84876323904     PISSN: 10020829     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1002-0829.2012.05.001     Document Type: Review

References (121)

1. Garakani A, Mathew S J, Charney D S. Neurobiology of anxiety disorders and implications treatment. Mt Sinai J Med 2006; 73(7): 941-949.
2. Makkar S R, Zhang S Q, Cranney J. Behavioral and neural analysis of GABA in the acquisition, consolidation, reconsolidation, and extinction of fear memory. Neuropsychopharmacology 2010; 35(8): 1625-1652.
3. Kim J J. Serotonin, stress, and conditioning. Biol Psychiatry 2008; 63(9): 819-820.
4. Davis M, Myers K M, Chhatwal J, Ressler K J. Pharmacological treatments that facilitate extinction of fear: relevance to psychotherapy. NeuroRx 2006; 3(1): 82-96.
5. Fendt M, Fanselow M S. The neuroanatomical and neurochemical basis of conditioned fear. Neurosci Biobehav Rev 1999; 23(5): 743-760.
6. Klüver H, Bucy P C. Preliminary analysis of the temporal lobes in monkeys. Biol Psychiatry 1939; 42: 461-471.
7. Weiskrantz L. Behavioral changes associated with ablations of the amygdaloid complex in monkeys. J Comp Physiol Psychol 1956; 49(4): 381-391.
8. Blanchard D C, Blanchard R J. Innate and conditioned reactions to threat in rats with amygdaloid lesions. J Comp Physiol Psychol 1972; 81(2): 281-290.
9. Maren S. Neurobiology of Pavlovian fear conditioning. Annu Rev Neurosci 2001; 24: 897-931.
10. Brodal A. The amygdaloid nucleus in the rat. J Comp Neurol 1947; 87: 1-16.
11. Campeau S, Davis M. Involvement of the central nucleus and basolateral complex of the amygdala in fear conditioning measured with fear-potentiated startle in rats trained concurrently with auditory and visual conditioned stimuli. J Neurosci 1995; 15: 2301-2311.
12. LeDoux J E, Cicchetti P, Xagoraris A, Romanski L M. The lateral amygdaloid nucleus: sensory interface of the amygdala in fear conditioning. J Neurosci 1990; 10(4): 1062-1069.
13. Amorapanth P, LeDoux J E, Nader K. Different lateral amygdala outputs mediate reactions and actions elicited by a fear-arousing stimulus. Nat Neurosci 2000; 3(1): 74-79.
14. Iwata J, LeDoux J E, Meeley M P, Arneric S, Reis D J. Intrinsic neurons in the amygdaloid field projected to by the medial geniculate body mediate emotional responses conditioned to acoustic stimuli. Brain Res 1986; 383(1-2): 195-214.
15. Kim M, Davis M. Lack of a temporal gradient of retrograde amnesia in rats with amygdala lesions assessed with the fear potentiated startle paradigm. Behav Neurosci 1993; 107(6): 1088-1092.
16. Young B J, Leaton R N. Amygdala central nucleus lesions attenuate acoustic startle stimulus-evoked heart rate changes in rats. Behav Neurosci 1996; 110(2): 228-237.
17. Kim J J, Fanselow M S. Modality-specific retrograde amnesia of fear. Science 1992; 256(5057): 675-677.
18. Maren S, Fanselow M S. Synaptic plasticity in the basolateral amygdala induced by hippocampal formation stimulation in vivo. J Neurosci 1995; 15(11): 7548-7564.
19. Phillips R G, LeDoux J E. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci 1992; 106(2): 274-285.
20. Fanselow M S. Contextual fear, gestalt memories, and the hippocampus. Behav Brain Res 2000; 110(1-2): 73-81.
21. Maren S, Aharanov G, Fanselow M S. Neurotoxic lesions of the dorsal hippocampus and Pavlovian fear conditioning in rats. Behav Brain Res 1997; 88(2): 261-274.
22. Squire L R, Zola Morgan S. The medial temporal lobe memory system. Science 1991; 253(5026): 1380-1386.
23. Morgan M A, LeDoux J E. Differential contribution of dorsal and ventral medial prefrontal cortex to the acquisition and extinction of conditioned fear in rats. Behav Neurosci 1995; 109(4): 681-688.
24. Morgan M A, Romanski L M, LeDoux J E. Extinction of emotional learning: contribution of medial prefrontal cortex. Neurosci Lett 1993; 163(1): 109-113.
25. Gewirtz J C, Falls W A, Davis M. Normal conditioned inhibition and extinction of freezing and fear-potentiated startle following electrolytic lesions of medical prefrontal cortex in rats. Behav Neurosci 1997; 111(4): 712-726.
26. Carrive P, Leung P, Harris J, Paxinos G. Conditioned fear to context is associated with increased fos expression in the caudal ventrolateral region of the midbrain periaqueductal gray. Neuroscience 1997; 78(1): 165-177.
27. Li X B, Inoue T, Nakagawa S, Koyama T. Effect of mediodorsal thalamic nucleus lesion on contextual fear conditioning in rats. Brain Research 2004; 1008(2): 261-272.
28. Klein D F. Delineation of two drug-responsive anxiety syndromes. Psychophamacologia 1964; 5: 397-408.
29. Fuller R W. Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. Life Sci 1994; 55(3): 163-167.
30. Zohar J, Westenberg H G. Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors. Acta Psychiatr Scand Suppl 2000; 403: 39-49.
31. Inoue T, Izumi T, Li X B, Huang J Z, Kitaichi Y, Nakagawa S, et al. Biological basis of anxiety disorders and serotonergic anxiolytics. Nihon Shinkei Seishin Yakurigaku Zasshi 2004; 24(3): 125-131.
32. Zanoveli J M, Carvalho M C, Cunha J M, Brandão M L. Extracellular serotonin level in the basolateral nucleus of the amygdala and dorsal periaqueductal gray under unconditioned and conditioned fear states: an in vivo microdialysis study. Brain Res 2009; 1294: 106-115.
33. Yokoyama M, Suzuki E, Sato T, Maruta S, Watanabe S, Miyaoka H. Amygdalic levels of dopamine and serotonin rise upon exposure to conditioned fear stress without elevation of glutamate. Neurosci Lett 2005; 379(1): 37-41.
34. Shida Y, Hashiguchi H, Takeda R, Ishizuka Y, Mitsuyama Y, Kannan H, et al. Conditioned-fear stress increases Fos expression in monoaminergic and GABAergic neurons of the locus coeruleus and dorsal raphe nuclei. Synapse 2002; 45(1): 46-51.
35. Izumi T, Inoue T, Kitaichi Y, Nakagawa S, Koyama T. Target brain sites of the anxiolytic effect of citalopram, a selective serotonin reuptake inhibitor. Eur J Pharmacol 2006; 534(1-3): 129-132.
36. Tada K, Kasamo K, Suzuki T, Matsuzaki Y, Kojima T. Endogenous 5-HT inhibits firing activity of hippocampal CA1 pyramidal neurons during conditioned fear stress-induced freezing behavior through stimulating 5-HT1A receptors. Hippocampus 2004; 14(2): 143-147.
37. Dai J X, Han H L, Tian M, Cao J, Xiu J B, Song N N, et al. Enhanced contextual fear memory in central serotonin-deficient mice. Proc Natl Acad Sci USA 2008; 105(33): 11981-11986
38. Maki Y, Inoue T, Izumi T, Muraki I, Ito K, Kitaichi Y, et al. Monoamine oxidase inhibitors reduce conditioned fear stress-induced freezing behavior in rats. Eur J Pharmacol 2000; 406(3): 411-418.
39. Hashimoto S, Inoue T, Koyama T. Serotonin reuptake inhibitors reduce conditioned fear stress-induced freezing behavior in rats. Psychopharmacology 1996; 123(2): 182-186.
40. Inoue T, Li X B, Abekawa T, Kitaichi Y j, Izumi T, Nakagawa S, et al. Selective serotonin reuptake inhibitor reduces conditioned fear through its effect in the amygdala. Eur J Pharmacology 2004; 497(3): 311-316.
41. Santos J M, Martinez R C, Brandäo M L. Effects of acute and subchronic treatments with fluoxetine and desipramine on the memory of fear in moderate and high-intensity contextual conditioning. Eur J Pharmacol 2006; 542(1-3): 121-128.
42. Miyamoto J, Tsuji M, Takeda H, Ohzeki M, Nawa H, Matsumiya T. Characterization of the anxiolytic-like effects of fluvoxamine, milnacipran and risperidone in mice using the conditioned fear stress paradigm. Eur J Pharmacol 2004; 504(1-2): 97-103.
43. Takamura N, Masuda T, Inoue T, Nakagawa S, Koyama T. The effects of the co-administration of the α1-adrenoreceptor antagonist prazosin on the anxiolytic effect of citalopram in conditioned fear stress in the rat. Prog Neuropsychopharmacol Biol Psychiatry 2012; 39(1): 107-111.
44. Kakui N, Yokoyama F, Yamauchi M, Kitamura K, Imanishi T, Inoue T, et al. Anxiolytic-like profile of mirtazapine in rat conditioned fear stress model: Functional significance of 5-hydroxytryptamine 1A receptor and alpha1-adrenergic receptor. Pharmacol Biochem Behav 2009; 92(3): 393-398.
45. De Vry J. 5-HT1A receptor agonists: recent developments and controversial issues. Psychopharmacology 1995; 121(1): 1-26.
46. Hindmarch I, Shillingford J, Kerr J S, Hesselink J M. The comparative psychopharmacology of 5-HT1A agonists. In: Stahl SM, Gastpar M, Keppel Hesselink JIM, Traber J. Serotonin 1A Receptors, in Depression and Anxiety. New York: Raven Press, 1992: 109-117.
47. Nishikawa H, Inoue T, Masui T, Izumi T, Koyama T. Effects of cytochrome P450 (CYP) 3A4 inhibitors on the anxiolytic action of tandospirone in rat contextual conditioned fear. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31(4): 926-931.
48. McQuade R, Sharp T. Functional mapping of dorsal and median raphe 5-hydroxytryptamine pathways in forebrain of the rat using microdialysis. J Neurochem 1997; 69(2): 791-796.
49. Fallon J H, Ciofi P. Distribution of monoamines within the amygdala. In: Aggleton JP. The amygdala: neurobiological aspects of emotion, memory, and mental dysfunction. New York: Wiley-Liss, 1992: 97-114.
50. Inoue T, Tsuchiya K, Koyama T. Serotonergic activation reduces defensive freezing in the conditioned fear paradigm. Pharmacol Biochem Behav 1996; 53(4): 825-831.
51. Li X B, Inoue T, Hashimoto S, Koyama T. Effect of chronic administration of flesinoxan and fluvoxamine on freezing behavior induced by conditioned fear. Eur J Pharmacol 2001; 425(1): 43-50.
52. Youn J, Misane I, Eriksson T M, Millan M J, Ogren S O, Verhage M, et al. Bidirectional modulation of classical fear conditioning in mice by 5-HT(1A) receptor ligands with contrasting intrinsic activities. Neuropharmacology 2009; 57(5-6): 567-576.
53. Li X B, Inoue T, Abekawa T, Weng S M, Nakagawa S, Izumi T. 5-HT1A receptor agonist affects fear conditioning through stimulations of the postsynaptic 5-HT1A receptors in the hippocampus and amygdala. Eur J Pharmacol 2006; 532(1): 74-80.
54. Stiedl O, Misane I, Spiess J, Ogren S O. Involvement of the 5-HT1A receptors in classical fear conditioning in C57BL/6J mice. J Neurosci 2000; 20(22): 8515-8527.
55. Almada R C, Borelli K G, Albrechet-Souza L, Brandão M L. Serotonergic mechanisms of the median raphe nucleus-dorsal hippocampus in conditioned fear: Output circuit involves the prefrontal cortex and amygdala. Behav Brain Res 2009; 203(2): 279-287.
56. Li X B, Inoue T, Koyama T. Effect of chronic treatment with the protein kinase C inhibitor staurosporine on the acquisition and expression of contextual fear conditioning. Eur J Pharmacol 2002; 441(13): 151-155.
57. McDevitt R A, Hiroi R, Mackenzie S M, Robin N C, Cohn A, Kim J J, et al. Serotonin 1B autoreceptors originating in the caudal dorsal raphe nucleus reduce expression of fear and depression-like behavior. Biol Psychiatry 2011; 69(8): 780-787.
58. Muraki I, Inoue T, Koyama T. Effect of co-administration of the selective 5-HT1A receptor antagonist WAY 100,635 and selective 5-HT1B/1D receptor antagonist GR 127,935 on anxiolytic effect of citalopram in conditioned fear stress in the rat. Eur J Pharmacol 2008; 586(1-3): 171-178.
59. Collingridge G L, Bliss T V P. NMDA receptors-their role in longterm potentiation. Trends Neurosci 1987; 10: 288-293.
60. Rogan M T, LeDoux J E. LTP is accompanied by commensurate enhancement of auditory-evoked responses in a fear conditioning circuit. Neuron 1995; 15(1): 127-136.
61. Maren S. Long-term potentiation in the amygdala: a mechanism for emotional learning and memory. Trends Neurosci 1999; 22(12): 561-567.
62. Huang Y Y, Martin K C, Kandel E R. Both protein kinase A and mitogen-activated protein kinase are required in the amygdala for the macromolecular synthesis-dependent late phase of longterm potentiation. J Neurosci 2000; 20(17): 6317-6325.
63. McKernan M G, Shinnick-Gallagher P. Fear conditioning induces a lasting potentiation of synaptic currents in vivo. Nature 1997; 390(6660): 607-611.
64. Rogan M T, Stäubli U V, LeDoux J E. Fear conditioning induces associative long-term potentiation in the amygdala. Nature 1997; 390(6660): 604-607.
65. Maren S, DeCola J P, Fanselow M S. Water deprivation enhances fear conditioning to contextual, but not discrete, conditional stimuli in rats. Behav Neurosci 1994; 108(3): 645-649.
66. Maren S, DeCola J P, Swain R A, Fanselow M S, Thompson R F. Parallel augmentation of hippocampal long-term potentiation, theta rhythm, and contextual fear conditioning in water-deprived rats. Behav Neurosci 1994; 108(1): 44-56.
67. Maren S, Fanselow M S. Appetitive motivational states differ in their ability to augment aversive fear conditioning in rats (Rattus norvegicus). J Exp Psychol: Anim Behav Process 1998; 24(3): 369-373.
68. Maren S, Aharonov G, Stote D L, Fanselow M S. N-methyldaspartate receptors in the basolateral amygdala are required for both acquisition and expression of conditional fear in rats. Behav Neurosci 1996; 110(6): 1365-1374.
69. Lee H, Kim J J. Amygdala NMDA receptors are critical for new fear learning in previously fear-conditioned rats. J Neurosci 1998; 18(20): 8444-8454.
70. Czerniawski J, Ree F, Chia C, Otto T. Dorsal versus ventral hippocampal contributions to trace and contextual conditioning: Differential effects of regionally selective nmda receptor antagonism on acquisition and expression. Hippocampus 2012; 22(7): 1528-1539.
71. Fendt M. Injections of the NMDA receptor antagonist aminophosphonopentanoic acid into the lateral nucleus of the amygdala block the expression of fear-potentiated startle and freezing. J Neurosci 2001; 21(11): 4111-4115.
72. Zhang W N, Bast T, Feldon J. The ventral hippocampus and fear conditioning in rats: different anterograde amnesias of fear after infusion of N-methyl-d-aspartate or its noncompetitive antagonist MK-801 into the ventral hippocampus. Behav Brain Res 2001; 126(1-2): 159-174.
73. André J M, Leach P T, Gould T J. Nicotine ameliorates NMDA receptor antagonist-induced deficits in contextual fear conditioning through high-affinity nicotinic acetylcholine receptors in the hippocampus. Neuropharmacology 2011; 60(4): 617-625.
74. Bast T, Zhang W N, Feldon J. Dorsal hippocampus and classical fear conditioning to tone and context in rats: effects of local NMDAreceptor blockade and stimulation. Hippocampus 2003; 13(6): 657-675.
75. Matus-Amat P, Higgins E A, Sprunger D, Wright-Hardesty K, Rudy J W. The role of dorsal hippocampus and basolateral amygdala NMDA receptors in the acquisition and retrieval of context and contextual fear memories. Behav Neurosci 2007; 121(4): 721-731.
76. Kim M, Campeau S, Falls W A, Davis M. Infusion of the non-NMDA receptor antagonist CNQX into the amygdala blocks the expression of fear-potentiated startle. Behav Neural Biol 1993; 59(1): 5-8.
77. Walker D L, Davis M. Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear. J Neurosci 1997; 17(23): 9375-9383.
78. Haller J, Nagy R, Toth M, Pelczer K G, Mikics E. NR2B subunitspecific NMDA antagonist Ro25-6981 inhibits the expression of conditioned fear: a comparison with the NMDA antagonist MK-801 and fluoxetine. Behav Pharmacol 2011; 22(2): 113-121.
79. Corcoran K A, Donnan M D, Tronson N C, Guzmán Y F, Gao C, Jovasevic V, et al. NMDA receptors in retrosplenial cortex are necessary for retrieval of recent and remote context fear memory. J Neurosci 2011; 31(32): 11655-11659.
80. Hillman B G, Gupta S C, Stairs D J, Buonanno A, Dravid S M. Behavioral analysis of NR2C knockout mouse reveals deficit in acquisition of conditioned fear and working memory. Neurobiol Learn Mem 2011; 95(4): 404-414.
81. Bourtchouladze R, Abel T, Berman N, Gordon R, Lapidus K, Kandel E R. Different training procedures recruit either one or two critical periods for contextual memory consolidation, each of which requires protein synthesis and PKA. Learn Mem 1998; 5(4-5): 365-374.
82. Schafe G E, Nadel N V, Sullivan G M, Harris A, LeDoux J E. Memory consolidation for contextual and auditory fear conditioning is dependent on protein synthesis, PKA, and MAP kinase. Learn Mem 1999; 6(2): 97-110.
83. Migues P V, Hardt O, Wu D C, Gamache K, Sacktor T C, Wang T Y, et al. PKMζ maintains memories by regulating GluR2-dependent AMPA receptor trafficking. Nat Neurosci 2010; 13(5): 630-634.
84. Rodrigues S M, Schafe G E, Ledoux J E. Molecular mechanisms underlying emotional learning and memory in the lateral amygdala. Neuron 2004; 44(1): 75-91.
85. Harris J A, Westbrook R F. Effects of benzodiazepine microinjection into the amygdala or periaqueductal gray on the expression of conditioned fear and hypoalgesia in rats. Behav Neurosci 1995; 109(2): 295-304.
86. Nagy J, Zambo K, Decsi L. Anti-anxiety action of diazepam after intra-amygdaloid application in the rat. Neuropharmacology 1979; 18(6): 573-576.
87. Pesold C, Treit D. The central and basolateral amygdala differentially mediate the anxiolytic effects of benzodiazepines. Brain Res 1995; 671(2): 213-221.
88. Helmstetter F J, Bellgowan P S. Effects of muscimol applied to the basolateral amygdala on acquisition and expression of contextual fear conditioning in rats. Behav Neurosci 1994; 108(5): 1005-1009.
89. Davis M. Diazepam and flurazepam: effects on conditioned fear as measured with the potentiated startle paradigm. Psychopharmacology (Berl) 1979; 62(1): 1-7.
90. Harris J A, Westbrook R F. Effects of benzodiazepine microinjection into the amygdala or periaqueductal gray on the expression of conditioned fear and hypoalgesia in rats. Behav Neurosci 1995; 109(2): 295-304.
91. Harris J A, Westbrook R F. The benzodiazepine midazolam does not impair Pavlovian fear conditioning but regulates when and where fear is expressed. J Exp Psychol Anim Behav Process 1999; 25(2): 236-246.
92. Harris J A, Westbrook R F. Contextual control over the expression of fear in rats conditioned under a benzodiazepine. Psychopharmacology (Berl) 2001; 156(1): 92-97.
93. Sanger D J, Joly D. Anxiolytic drugs and the acquisition of conditioned fear in mice. Psychopharmacology (Berl) 1985; 85(3): 284-288.
94. Guarraci F A, Frohardt R J, Kapp B S. Amygdaloid D1 dopamine receptor involvement in Pavlovian fear conditioning. Brain Res 1999; 827(1-2): 28-40.
95. Tang H H, McNally G P, Richardson R. The effects of FG7142 on two types of forgetting in 18-day-old rats. Behav Neurosci 2007; 121(6): 1421-1425.
96. Stork O, Ji F Y, Obata K. Reduction of extracellular GABA in the mouse amygdala during and following confrontation with a conditioned fear stimulus. Neurosci Lett 2002; 327(2): 138-142.
97. Shaban H, Humeau Y, Herry C, Cassasus G, Shigemoto R, Ciocchi S, et al. Generalization of amygdala LTP and conditioned fear in the absence of presynaptic inhibition. Nat Neurosci 2006; 9(8): 1028-1035.
98. Bergado-Acosta J R, Sangha S, Narayanan R T, Obata K, Pape H C, Stork O. Critical role of the 65-kDa isoform of glutamic acid decarboxylase in consolidation and generalization of Pavlovian fear memory. Learn Mem 2008; 15(3): 163-171.
99. DeLorey T M, Handforth A, Anagnostaras S G, Homanics G E, Minassian B A, Asatourian A, et al. Mice lacking the b3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome. J Neurosci 1998; 18(20): 8505-8514.
100. Davis M. NMDA receptors and fear extinction: implications for cognitive behavioral therapy. Dialogues Clin Neurosci 2011; 13(4): 463-474.
101. Davis M, Myers K M, Chhatwal J, Ressler K J. Pharmacological treatments that facilitate extinction of fear: Relevance to psychotherapy. NeuroRx 2006; 3(1): 82-96.
102. Cain C K, Blouin A M, Barad M. L-type voltage-gated calcium channels are required for extinction, but not for acquisition or expression, of conditional fear in mice. J Neurosci 2002; 22(20): 9113-9121.
103. Falls W A, Miserendino M J, Davis M. Extinction of fear potentiated startle: blockade by infusion of an NMDA antagonist into the amygdala. J Neurosci 1992; 12(3): 854-863.
104. Szapiro G, Vianna M R, McGaugh J L, Medina J H, Izquierdo I. The role of NMDA glutamate receptors, PKA, MAPK and CaMKII in the hippocampus in extinction of conditioned fear. Hippocampus 2003; 13(1): 53-58.
105. Santini E, Ge H, Ren K, Peña de Ortiz S, Quirk G J. Consolidation of fear extinction requires protein synthesis in the medial prefrontal cortex. J Neurosci 2004; 24(25): 5704-5710.
106. Lattal K M, Abel T. Different requirements for protein synthesis in acquisition and extinction of spatial preferences and contextevoked fear. J Neurosci 2001; 21(15): 5773-5880.
107. Kehoe E, Macrae M, Hutchinson C. MK-801 protects conditioned response from extinction in the rabbit nictitating membrane preparation. Psychobiology 1996; 24: 127-135.
108. Lee H, Kim J. Amygdalar NMDA receptors are critical for new fear learning in previously fear-conditioned rats. J Neurosci 1998; 18(20): 8444-8454.
109. Zimmerman J M, Maren S. NMDA receptor antagonism in the basolateral but not central amygdala blocks the extinction of Pavlovian fear conditioning in rats. Eur J Neurosci 2010; 31(9): 1664-1670.
110. Walker D L, Ressler K J, Lu K T, Davis M. Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats. J Neurosci 2002; 22(6): 2343-2351.
111. Ledgerwood L, Richardson R, Cranney J. Effects of D-cycloserine on extinction of conditioned freezing. Behav Neurosci 2003; 117(2): 341-349.
112. Ledgerwood L, Richardson R, Cranney J. D-Cycloserine and the facilitation of extinction of conditioned fear: consequences for reinstatement. Behav Neurosci 2004; 118(3): 505-513.
113. Vervliet B. Learning and memory in conditioned fear extinction: Effects of D-cycloserine. Acta Psychologica 2008; 127(3): 601-613.
114. Matsumoto M, Togashi H, Konno K, Koseki S, Hirata R, Izumi T, et al. Early postnatal stress alters the extinction of contextdependent conditioned fear in adult rats. Pharmacol Biochem Behav 2008; 89(3): 247-252.
115. Yamamoto S, Morinobu S, Fuchikami M, Kurata A, Kozuru T, Yamawaki S. Effects of single prolonged stress and D-cycloserine on contextual fear extinction and hippocampal NMDA receptor expression in a rat model of PTSD. Neuropsychopharmacology 2008; 33(9): 2108-2116.
116. Yang Y L, Chao P K, Ro L S, Wo Y Y, Lu K T. Glutamate NMDA receptors within the amygdala participate in the modulatory effect of glucocorticoids on extinction of conditioned fear in rats. Neuropsychopharmacology 2007; 32(5): 1042-1051.
117. Koseki H, Matsumoto M, Togashi H, Miura Y, Fukushima K, Yoshioka M. Alteration of synaptic transmission in the hippocampal-mPFC pathway during extinction trials of contextdependent fear memory in juvenile rat stress models. Synapse 2009; 63(9): 805-813.
118. McGaugh J L, Introini-Collison I B, Nagahara A H, Cahill L, Brioni J D, Castellano C. Involvement of the amygdaloid complex in neuromodulatory influences on memory storage. Neurosci Biobehav Rev 1990; 14(4): 425-431.
119. Izquierdo I, Pereira M E. Post-training memory facilitation blocks extinction but not retroactive interference. Behav Neural Biol 1989; 51(1): 108-113.
120. Harris J A, Westbrook R F. Evidence that GABA transmission mediates context-specific extinction of learned fear. Psychopharmacology (Berl) 1998; 140(1): 105-115.
121. Chhatwal J P, Myers K M, Ressler K J, Davis M. Regulation of gephyrin and GABAA receptor binding within the amygdala after fear acquisition and extinction. J Neurosci 2005; 25(2): 502-506.